Vitamin D Supplementation to Improve Ovulation in Women Ages 18 to 40 With Polycystic Ovary Syndrome
Led by The University of Hong Kong · Updated on 2024-05-14
220
Participants Needed
3
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effect of vitamin D supplementation on ovulation rates in women with polycystic ovary syndrome PCOS. This randomized, double-blind controlled trial focuses on women diagnosed with PCOS by the Rotterdam criteria who experience irregular menstrual cycles and anovulation. The study aims to assess ovulation and other reproductive, endocrine, and metabolic outcomes over one year of treatment.
Participants will be randomly assigned to either a vitamin D group or a placebo group. The vitamin D group will take 50,000 IU weekly for 4 weeks, then 50,000 IU every two weeks for 52 weeks. Participants who remain anovulatory after 6 months in both groups will receive a 6-month course of letrozole to induce ovulation. The placebo group will receive tablets that look like vitamin D but contain no active ingredient.
During the study, participants will undergo transvaginal ultrasounds and blood tests to monitor ovulation, hormone levels, and other health indicators. Researchers will track ovulation rate as the primary outcome, along with pregnancy rates, live births, metabolic measures, and body measurements for up to 12 months. The study includes safety monitoring related to vitamin D levels and calcium. Total participation lasts about one year.
CONDITIONS
Brief Title
Effect of Vitamin D on Ovulation Rate in Women With Polycystic Ovary Syndrome
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosed with PCOS according to the Rotterdam criteria
Agree to have transvaginal ultrasound examinations
You will not qualify if you...
Use of hormonal medications including contraception within 3 months before joining, except progestogen for withdrawal bleeding every 3 months
History of medical conditions or medications that affect vitamin D sensitivity or metabolism, such as active tuberculosis, sarcoidosis, kidney or liver failure, or parathyroid disease
Current use of insulin-sensitizing, lipid-lowering, or anti-hypertensive drugs
Expected use of the above medications during the next year
Known type 2 diabetes mellitus
Abnormal blood calcium levels
Refusal to join the study
Participants currently taking supplements must stop them prior to joining the study
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 12 months
Participants receive vitamin D supplementation or placebo for up to 12 months. Those who remain anovulatory after 6 months may receive letrozole treatment for ovulation induction for an additional 6 months.
Weekly visits for the first 4 weeks, then biweekly visits for up to 52 weeks; additional visits during letrozole treatment if applicable
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Apple Womens Health Study to Understand Menstrual Cycles and Gynecologic Health Conditions Using the Apple Research App
Study of Metabolic and Hormonal Features in Women Aged 18 to 45 with Polycystic Ovary Syndrome
Study of Oral Contraceptive Pills and Resistant Starch in Women with Polycystic Ovary Syndrome to Improve Heart and Metabolic Health
Understanding Androgen Excess and Metabolic Problems in Women with Polycystic Ovary Syndrome Using Detailed Body and Blood Analysis
Study of Fasting Insulin and Insulin Resistance by Age, Sex, Race, BMI, and PCOS Status
Study of Spironolactone Effects on Sleep-Related Hormone Patterns in Pubertal Girls With Hyperandrogenism
Evaluating Orlistat with Lifestyle Changes to Improve Metabolic and Hormonal Health in Women Aged 18-45 with Polycystic Ovary Syndrome
Vitamin D Supplementation to Improve Ovulation in Women Ages 18 to 40 With Polycystic Ovary Syndrome
Effectiveness of a Physical Activity Program with Levothyroxine and Metformin in Women Aged 20 to 40 with Polycystic Ovary Syndrome, Fatty Pancreas, and Subclinical Hypothyroidism
Glucose Monitoring Study in Women Over 18 With Polycystic Ovary Syndrome Using New Sensor Technology
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effect of vitamin D in addition to letrozole on the ovulation rate of women with polycystic ovary syndrome: protocol of a multicentre randomised double-blind controlled trial.